Advances in genetic technologies are paving the way to elucidate the pathophysiology of autism, according to an article in Lancet Neurology.
A $4.6 million Simons Foundation grant will fund enrollment and initial data collection, but additional resources are necessary for genetic analysis and hypothesis generation.
Harvard Medical School's Kaitlin Samocha is studying de novo mutations linked to complex diseases like autism and schizophrenia.
With $4.6M in funding from the Simons Foundation, Kaiser will collect data from 5,000 families in Northern California.
David Glazer from Google Genomics provided an update on the MSSNG project, a collaboration between Autism Speaks, The Hospital for Sick Children in Toronto, and Google.
By focusing on girls with severe autism, Johns Hopkins researchers uncovered four candidate genes for the disorder, including one involved in neuronal development and chromatin biology.
Researchers uncover possible salivary protein markers for autism.
The company raised about $12.2 million in a second tranche of the Series C round, which will be used to increase adoption of its ASD diagnostic tests.
Genoma will commercialize the Arisk test outside the US and will provide genetic consulting services and diagnostics services to children with ASD and their parents.
A team of researchers in the UK examined DNA methylation patterns of nearly 180 fetal brain samples, finding significant DNA methylation changes at a number of sites.
Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.
In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.